Effective therapeutic use of rituximab in refractory Wegener's granulomatosis

This publication has 9 references indexed in Scilit:

• Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis
  New England Journal of Medicine, 2004
• Prospective Study of TNFα Blockade with Infliximab in Anti-Neutrophil Cytoplasmic Antibody-Associated Systemic Vasculitis
  Journal of the American Society of Nephrology, 2004
• Rituximab in the treatment of acquired factor VIII inhibitors
  Blood, 2002
• An open study of B lymphocyte depletion in systemic lupus erythematosus
  Arthritis & Rheumatism, 2002
• Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice
  Journal of Clinical Investigation, 2002
• The Unique Antigen Receptor Signaling Phenotype of B-1 Cells Is Influenced by Locale but Induced by Antigen
  The Journal of Immunology, 2002
• Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy
  Arthritis & Rheumatism, 2001
• Differential B- and T-cell activation in Wegener’s granulomatosis
  Published by Elsevier ,1999
• Anti-neutrophil Cytoplasmic Antibodies and Disease Activity During Long-Term Follow-up of 70 Patients with Systemic Vasculitis
  Nephrology Dialysis Transplantation, 1991